Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 12/15/21 → 4/29/26 |
Funding
- Exelixis Inc.: $166,708.00
Phase II Clinical Trial Evaluating Cabozantinib and Pembrolizumab in Second-Line Therapy for Metastatic Pancreatic Adenocarcinoma
- Kim, Joseph (PI)
- Fan, Whei-Mei (CoI)
- Gao, Mei (CoI)
- Higashi, Richard (CoI)
- Rueckert, Justin (CoI)
- Qasem, Shadi (Former CoI)